European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Grant programme · United States

Cancer Detection and Diagnosis Research

Cancer Detection and Diagnosis Research (United States): the programme's calls and grants. 52 calls on the site, 10 open now; its calls usually open in November. Data as of 17 November 2026; updated daily.

Funder: National Institutes of Health (Department of Health and Human Services)

Grants in the last 24 months
0
Recipients
0
Open calls
10
Calls on the site
52

Calls usually open in November

About the programme

Objectives: To improve screening and early detection strategies and to develop accurate diagnostic techniques and methods for predicting the course of disease in cancer patients. Screening and Early Detection research includes development of strategies to decrease cancer mortality by finding tumors…

Read more at the source

Open calls

Grant callStatusCloses
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) (round Nov 2024 – Jan 2027)Open7 January 2027
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)Open11 January 2027
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)Open11 February 2027
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) (round Nov 2024 – Jan 2028)Open7 January 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) (round Dec 2024 – Jan 2028)Open7 January 2028
Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)Forthcoming—
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)Forthcoming—
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)Forthcoming—
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)Forthcoming—
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)Forthcoming—

Earlier calls

Grant callStatusCloses
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (round Jun 2026 – Nov 2026)Closed10 November 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (round Jun 2026 – Nov 2026)Closed10 November 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) (round Oct 2024 – Oct 2026)Closed14 October 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) (round Oct 2024 – Oct 2026)Closed14 October 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) (round Oct 2024 – Oct 2026)Closed14 October 2026
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) (round Nov 2024 – May 2026)Closed4 May 2026
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) (round Dec 2024 – Dec 2025)Closed9 December 2025
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (round Dec 2024 – Dec 2025)Closed9 December 2025
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) (round Dec 2024 – Dec 2025)Closed9 December 2025
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (round Dec 2024 – Dec 2025)Closed9 December 2025
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (round Dec 2024 – Dec 2025)Closed9 December 2025
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) (round Dec 2024 – Dec 2025)Closed9 December 2025
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (round Dec 2024 – Dec 2025)Closed9 December 2025
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) (round Oct 2023 – Oct 2025)Closed15 October 2025
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) (round Nov 2024 – May 2025)Closed7 May 2025
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) (round Nov 2024 – May 2025)Closed7 May 2025
Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)Closed24 February 2025
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)Closed24 February 2025
Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)Closed24 February 2025
NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)Closed24 February 2025

Grant calendars

Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.

Questions and answers

When does Cancer Detection and Diagnosis Research open calls?
10 open now: Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems… (7 January 2027), Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) (11 January 2027), Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Bi… (11 February 2027), …. Its calls usually open in November.